Keyword [Programmed death-ligand]
Result: 121 - 140 | Page: 7 of 8 |
| 121. | The Expression And Significance Of PD-1,PD-L1,and PD-L2 In T Cell Subsets And Myeloma Plasma Cells Of Multiple Myeloma |
| 122. | Associations Of The Status And Prognostic Role Of Mismatch Repair (MMR) Status,PD-L1 Expression,and Tumor-infiltrating Leukocytes In Familial Adenomatous Polyposis |
| 123. | Effects Of Methionine Starvation On Proliferation,apoptosis And Immune Tolerance Of Gastric Cancer Cells |
| 124. | Systematic Review Of The Efficacy And Safety Of Immunotherapy Combined With Chemotherapy In The First-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma |
| 125. | Expression And Prognostic Value Of Tumor-infiltrating Lymphocytes And PD-L1 In Hepatocellular Carcinoma |
| 126. | Expression Of MicroRNA And PD-L1 In Different Human Breast Cancer Cells |
| 127. | Construction For Prognostic Assessment Of Triple-negative Breast Cancer,Expressions And Clinical Significance Of Immune Checkpoint-related Proteins |
| 128. | Negative Correlation Of MicroRNA And PD-L1 Expression In Breast Cancer Cells And Target Blocking The Expression Of PD-L1 |
| 129. | Clinical Role Of CD39 Expression In Head And Neck Squamous Cell Carcinoma And Its Related Impact Factors |
| 130. | Theoretical Investigations On The Mechanism Of Dimerizationmodes Transformation In Programmed Death Ligand-1 Protein |
| 131. | Identification And Characterization Of Small Molecule Inhibitors Against PD-L1 |
| 132. | The Roles And Related Mechanisms Of Low-density Granulocytes On T-SPOT.TB Detection |
| 133. | The Expression And Significance Of PD-L1 In Different Stages Of Helicobacter Pylori Gastritis |
| 134. | Expressive Levels And Clinical Significance Of SPD-1 And SPD-L1 In Peripheral Blood Of Patients With Hematological Malignancies |
| 135. | SYVN1 Ubiquitinates FoxO1 To Induce P-catenin Nuclear Translocation,PD-LI-mediated Metastasis,and Immune Evasion Of Hepatocellular Carcinoma |
| 136. | Endothelial Targeting Blockade Of Programmed Death-Ligand1 (PD-L1) Attenuates Sepsis Induced Acute Lung Injury |
| 137. | The Application Study On PD-L1 Expression,Immunotherapy Efficacy And Complication Prediction In Non-small Cell Lung Cancer Based On CT Radiomics |
| 138. | Experimental Study Of Sorafenib Combined With Anti-PD-L1 Antibody In The Treatment Of Hepatocellular Carcinoma And Multimodal Imaging Evaluation Of Its Efficacy |
| 139. | IL-2 Mutein Enhance The Efficacy Of PD-1 Monoclonal Antibody Immunotherapy And Its Related Mechanisms |
| 140. | Effects Of Secretion Phenotype Of Senescent Tumor Cells On Tumor Migration, Invasion And Tumor Immune Micro-Environment And Its Mechanism |
|
